5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand
Authors
Keywords
-
Journal
BLOOD
Volume 119, Issue 18, Pages 4242-4252
Publisher
American Society of Hematology
Online
2012-03-23
DOI
10.1182/blood-2011-09-382770
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non-Small Cell Lung Cancers
- (2012) G. Heller et al. CLINICAL CANCER RESEARCH
- The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria-mediated apoptosis and DNA damage in p53 mutant leukemic T cells
- (2011) María J. Ruiz-Magaña et al. INTERNATIONAL JOURNAL OF CANCER
- Azacytidine and Decitabine Induce Gene-Specific and Non-Random DNA Demethylation in Human Cancer Cell Lines
- (2011) Sabine Hagemann et al. PLoS One
- Sustained exposure to the DNA demethylating agent, 2′-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy
- (2010) Michael Schnekenburger et al. BIOCHEMICAL PHARMACOLOGY
- Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)
- (2010) S. Thepot et al. BLOOD
- Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536
- (2010) K. V. Gleixner et al. CANCER RESEARCH
- Combination of Human Fas (CD95/Apo-1) Ligand with Adriamycin Significantly Enhances the Efficacy of Antitumor Response
- (2010) Zhongchen Liu et al. Cellular & Molecular Immunology
- Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma
- (2010) Hiroshi Hirata et al. INTERNATIONAL JOURNAL OF CANCER
- A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
- (2010) Paul W. Hollenbach et al. PLoS One
- Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
- (2009) K.-H. Lim et al. BLOOD
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients
- (2009) Luis Escribano et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells
- (2009) C Flotho et al. LEUKEMIA
- 5-Aza-2′-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis
- (2009) Benigno C. Valdez et al. LEUKEMIA RESEARCH
- Current status of epigenetic treatment in myelodysplastic syndromes
- (2008) Andrea Kuendgen et al. ANNALS OF HEMATOLOGY
- Phase II Study of Dasatinib in Philadelphia Chromosome-Negative Acute and Chronic Myeloid Diseases, Including Systemic Mastocytosis
- (2008) S. Verstovsek et al. CLINICAL CANCER RESEARCH
- Dasatinib therapy for systemic mastocytosis: four cases
- (2008) Duncan Purtill et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Azacytidine causes complex DNA methylation responses in myeloid leukemia
- (2008) C. Stresemann et al. MOLECULAR CANCER THERAPEUTICS
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)
- (2007) P.W. Wijermans et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now